Cargando…

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32

BACKGROUND: Chronic hepatitis B virus (HBV) infections are a global health problem. There is a need for therapeutic strategies blocking continuous infection of liver cells. The grass pollen allergy vaccine BM32 containing the preS domain of the large HBV surface protein (LHBs) as immunogenic carrier...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tulaeva, Inna, Cornelius, Carolin, Zieglmayer, Petra, Zieglmayer, René, Schmutz, René, Lemell, Patrick, Weber, Milena, Focke-Tejkl, Margarete, Karaulov, Alexander, Henning, Rainer, Valenta, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502672/ https://www.ncbi.nlm.nih.gov/pubmed/32855110 http://dx.doi.org/10.1016/j.ebiom.2020.102953

Ejemplares similares

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational
por: Curin, Mirela, et al.
Publicado: (2021)

Allergen challenge tests in allergen immunotherapy: State of the art
por: Zieglmayer, Petra, et al.
Publicado: (2023)

Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
por: Roth-Walter, Franziska, et al.
Publicado: (2018)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
por: Zieglmayer, Petra, et al.
Publicado: (2020)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018)

Albumins represent highly cross-reactive animal allergens
por: Liu, Zicheng, et al.
Publicado: (2023)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects
por: Jordakieva, Galateja, et al.
Publicado: (2014)

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
por: Resch, Yvonne, et al.
Publicado: (2016)

Epitope specificity determines cross‐protection of a SIT‐induced IgG(4) antibody
por: Gadermaier, E., et al.
Publicado: (2015)

Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro‐arrayed allergens
por: Garib, V., et al.
Publicado: (2017)

Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus: A Possible Biomarker for Allergic Asthma
por: Sarzsinszky, Eszter, et al.
Publicado: (2020)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen
por: Dorofeeva, Yulia, et al.
Publicado: (2019)

Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe
por: Mothes‐Luksch, N., et al.
Publicado: (2017)

A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help
por: Narayanan, Meena, et al.
Publicado: (2017)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants
por: Gattinger, Pia, et al.
Publicado: (2022)

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5
por: Levin, M, et al.
Publicado: (2014)

Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021)

IgE epitope proximity determines immune complex shape and effector cell activation capacity
por: Gieras, Anna, et al.
Publicado: (2015)

Biochemical, Biophysical and IgE-Epitope Characterization of the Wheat Food Allergen, Tri a 37
por: Pahr, Sandra, et al.
Publicado: (2014)

Tracing antigen signatures in the human IgE repertoire
por: Marth, Katharina, et al.
Publicado: (2010)

Clustering of conformational IgE epitopes on the major dog allergen Can f 1
por: Curin, Mirela, et al.
Publicado: (2017)

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens
por: Huang, Huey‐Jy, et al.
Publicado: (2019)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
por: Tulaeva, Inna, et al.
Publicado: (2020)

Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G
por: Borochova, Kristina, et al.
Publicado: (2020)

Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross‐reactivity
por: Curin, M., et al.
Publicado: (2018)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Comparison of the Specificities of IgG, IgG-Subclass, IgA and IgM Reactivities in African and European HIV-Infected Individuals with an HIV-1 Clade C Proteome-Based Array
por: Gallerano, Daniela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hs0m2ogkdief767t14dkv9oqm4